News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Meet the speakers of the 9th Annual Conference of ELLOK: Hugo R. Soares – Hellenic Cancer Federation (ELLOK)
Hugo R. Soares/ellok.org
Feb 2, 2025, 13:57

Meet the speakers of the 9th Annual Conference of ELLOK: Hugo R. Soares – Hellenic Cancer Federation (ELLOK)

Meet the speakers of our Conference!

Hugo R. Soares will participate in the 9th Annual Conference of ELLOK, in the roundtable titled: European Program ECHoS | Establishing of Cancer Mission Hubs: Networks and Synergies: The Creation of Cancer Mission National Hubs.

Read more about the conference.

cancer ELLOK European Program ECHoS Hugo R. Soares OncoDaily Oncology
Special Coverage
Blog
Feb 2, 2025, 13:57
Meet the speakers of the 9th Annual Conference of ELLOK: Hugo R. Soares - Hellenic Cancer Federation (ELLOK)
Blog
Feb 2, 2025, 10:26
Michael Holtz: Join me for "Highlights from ASCO GI Webinar" hosted by Fight Colorectal Cancer
Blog
Feb 2, 2025, 08:16
Key insights on the future of people-centred care by Daiming Fan - UICC
Blog
Feb 2, 2025, 07:49
Marking the launch of ATOM Coalition initiatives in Zambia - UICC
Blog
Feb 2, 2025, 06:01
Omid Hamid: The evolving standards of care in melanoma and other cutaneous malignancies
Blog
Feb 2, 2025, 05:57
Senthil Kumar: Systemic Management of Advanced/Metastatic HR+, HER2- Breast Cancer
Blog
Feb 2, 2025, 05:53
Enes Erul: The ESMO Resilience Task Force workshop has kicked off
Career
Feb 2, 2025, 05:26
Rawad Rihani was appointed to the SIOP WLPO Network Steering Group
Blog
Feb 2, 2025, 05:24
Ramy Sedhom: Excited to host Allison J. Applebaum for Virtual Grand Rounds
Science
Feb 2, 2025, 04:46
SBRT for oligoprogression in HCC, suggested by Nina Niu Sanford
Science
Feb 2, 2025, 04:34
Timothée Olivier: How many patients with advanced or metastatic cancer respond to immunotherapy
Blog
Feb 2, 2025, 04:22
Encorafenib, cetuximab, and chemotherapy in BRAF-mutant colorectal cancer